Drug-labels.com

Praluent (Sanofi-Aventis Canada, 75 mg, 150 mg): Uses, Side Effects and Dosage

Updated:
Facts
Status:
Prescription (Rx) Current status: Cancelled Post Market
Strength:
75 mg, 150 mg
Active ingredient:
ATC code:

Patient Medication Information: uses, side effects, how to take - Praluent (Sanofi-Aventis Canada, 75 mg, 150 mg)

What is PRALUENT used for?

PRALUENT is used:

  • To reduce the risk of heart attack, stroke, and certain types of heart procedures (to restore blood flow to the heart) in adults with cardiovascular disease.
  • To reduce low density lipoprotein cholesterol (LDL-C) levels in adults with high choles-terol levels (hypercholesterolemia, heterozygous familial and non-familial.

PRALUENT can be used along with lifestyle changes, by itself or with other medicines (such as statins or ezetimibe) to treat patients with high cholesterol. Continue to follow your cholesterol-lowering diet while taking this medicine.

It is not known if PRALUENT is safe and effective in children.

How does PRALUENT work?

PRALUENT is an injectable medicine that belongs to a type of medicines called PCSK9 inhibi-tors.

  • PRALUENT is a fully human monoclonal antibody that blocks a protein called PCSK9 (proprotein convertase subtilisin kexin type 9).
  • PCSK9 is a protein secreted by liver cells.
  • LDL (“bad”) cholesterol is normally removed from the blood by binding to specific re-ceptors (docking stations) on liver cells. PCSK9 lowers the number of LDL receptors available to remove LDL cholesterol from the blood.
  • PRALUENT blocks PCSK9 and thereby increases the number of receptors available to remove LDL cholesterol from the blood. This results in lower LDL cholesterol levels.

What are the ingredients in PRALUENT?

Medicinal ingredients: alirocumab

Non-medicinal ingredients: histidine, polysorbate 20, sucrose and water for injection

PRALUENT comes in the following dosage forms:

  • Pre-filled pen
  • Pre-filled syringe

Do not use PRALUENT if:

  • you are allergic to alirocumab or to any of the other ingredients in this medicine

To help avoid side effects and ensure proper use of PRALUENT, talk to your healthcare professional about any health conditions or problems you may have before taking this med-icine, including if you:

  • have allergies. If you have a serious allergic reaction, stop using PRALUENT and tell your doctor or pharmacist.
  • are pregnant or intend to get pregnant. Tell your doctor or pharmacist before using this medicine. The use of PRALUENT is not recommended during pregnancy.

  • are breastfeeding or plan to breastfeed. Tell your doctor or pharmacist before using this medicine. The use of PRALUENT is not recommended during breast-feeding.

Other warnings you should know about:

There is no experience with PRALUENT in children and adolescents less than 18 years of age. Therefore, the use of PRALUENT is not recommended in this age group.

Tell your healthcare professional about all the medicines you take, including any drugs, vitamins, minerals, natural supplements or alternative medicines.

How to take PRALUENT:

PRALUENT is injected under the skin (subcutaneous use) of your upper leg (thigh), stomach area (abdomen), or upper arm.

Always check the label of your pre-filled pen or pre-filled syringe to make sure you have the cor-rect product and the correct strength of PRALUENT before each injection.

Remove PRALUENT pen or syringe from refrigerator approximately 30 to 40 min before injec-tion to allow the solution to come to room temperature.

Choose a different spot each time you inject (e.g. right thigh then left thigh, or right abdomen then left abdomen).

Do not inject into areas where the skin is injured, tender, hard, red or hot.

Do not inject PRALUENT together with other injectable medicines at the same injection site.

PRALUENT comes as a single-dose (1 time) pre-filled pen (autoinjector), or as a single-dose pre-filled syringe. Your healthcare provider will prescribe the type and dose that is best for you.

Before starting PRALUENT, you should be on a diet to lower your cholesterol. You should stay on this cholesterol lowering diet while taking PRALUENT.

If your doctor has prescribed PRALUENT along with a statin or other cholesterol lowering med-icine, follow your doctor’s instructions on how to take these medicines together. In this case, please read the dosage instructions in the package leaflet of the other medicines.

Ask your doctor if you have any further questions on how to use PRALUENT.

Learning how to use the pre-filled pen or pre-filled syringe

Before you use the pre-filled pen or the pre-filled syringe for the first time, your doctor, pharma-cist or nurse will show you how to inject PRALUENT.

  • Always read the "Instructions for Use" provided in the box.
  • Always use the pre-filled pen or the pre-filled syringe as described in the “Instructions for Use”.

Usual dose:

PRALUENT is available as 75 mg or 150 mg for subcutaneous administration. Your doctor will tell you which dosage (75 mg or 150 mg every 2 weeks or 300 mg every 4 weeks) is right for you.

To give the 300 mg dose, give two 150 mg injections in a row at two different injection sites.

Do not stop using PRALUENT without talking with your doctor. If you stop using PRALUENT, your cholesterol levels can increase.

Overdose:

If you think you have taken too much PRALUENT, contact your healthcare professional, hos-pital emergency department or regional Poison Control Centre immediately, even if there are no symptoms.

Missed Dose:

If you miss a dose of PRALUENT, inject your missed dose as soon as you are able to do so, within 7 days. Then take your next dose at your regular scheduled time:

  • If you take PRALUENT every 2 weeks, take your next dose 2 weeks from the day you missed your dose.
  • If you take PRALUENT every 4 weeks, take your next dose 4 weeks from the day you missed your dose.

If you miss a dose by more than 7 days:

  • If you take PRALUENT every 2 weeks, wait until your next dose scheduled to re-start.
  • If you take PRALUENT every 4 weeks, start a new schedule from the time you remem-ber to take your dose.

In case you are not sure when to inject PRALUENT, call your doctor, nurse or pharmacist.

What are possible side effects from using PRALUENT?

PRALUENT may cause allergic reactions that can be severe and require treatment in a hospital. Call your healthcare provider or go to the nearest hospital emergency room right away if you have any symptoms of an allergic reaction, including a severe rash, redness, severe itching, swelling of the face, lips, throat or tongue, or trouble breathing.

These are not all the possible side effects you may feel when taking PRALUENT. If you experi-ence any side effects not listed here, contact your healthcare professional. Please also see “Do not use PRALUENT if” and “Other warnings you should know about”.

Common (may affect up to 1 in 10 people)

  • Redness, swelling, pain, tenderness, or bruising (hematoma) where the injection is given (local injection site reactions)
  • Symptoms of the common cold
  • Itching (pruritus)

Rare (may affect up to 1 in 1,000 people):

  • Allergic reactions
  • Hypersensitivity vasculitis: a specific form of allergic reaction, with symptoms such as rash or purple-colored spots on the skin, diarrhea.
  • Hives (urticaria)
  • Reddish skin spots, sometimes with blisters (nummular eczema)

Serious side effects and what to do about them

Symptom / effectTalk to your healthcare professionalStop taking drug and get immediate medical help
Only if severeIn all cases

RARE

(may affect up to 1 in 1,000 people)

Allergic reactions✓
Hypersensitivity vasculitis, which is a specific form of allergic reaction. Symptoms may include diarrhea, rash, or purple-colored spots on the skin (purpura)✓

If you have a troublesome symptom or side effect that is not listed here or becomes bad enough to interfere with your daily activities, talk to your healthcare professional.

Reporting Side Effects

You can report any suspected side effects associated with the use of health products to Health Canada by:

  • Visiting the Web page on Adverse Reaction Reporting (https://www.canada.ca/en/health-canada/services/drugs-healthproducts/medeffect-canada.html) for information on how to report online, by mail or by fax; or
  • Calling toll-free at 1-866-234-2345.

NOTE: Contact your health professional if you need information about how to manage your side effects. The Canada Vigilance Program does not provide medical advice.

Storage:

Keep out of reach and sight of children.

Do not use this medicine after the expiry date which is stated on the label and carton.

Store in a refrigerator (2°C - 8°C). Do not freeze.

Keep the pen or the syringe in the outer carton in order to protect from light.

Do not expose to extreme heat.

PRALUENT should be allowed to warm to room temperature prior to use. PRALUENT should be used as soon as possible after it has warmed up (in 30 to 40 min). When taken out of the re-frigerator to warm up the pen or the syringe, do not put near a heat source or in direct sunlight. Do not keep PRALUENT for more than 30 days at room temperature.

Do not use this medicine if the solution is discolored or cloudy, or if it contains visible flakes or particles.

After use, put the pen or the syringe into a puncture-resistant container. Always keep the con-tainer out of the reach of children. Ask your health care provider or pharmacist how to throw away the container. Do not recycle the container.

Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.

If you want more information about PRALUENT:

  • Talk to your healthcare professional
  • Find the full product monograph that is prepared for healthcare professionals and in-cludes this Patient Medication Information by visiting the Health Canada website (http://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/drug-product-database.html); the manufacturer’s website: www.sanofi.ca, or by calling 1-800-265-7927.

Last revised: December 6, 2019

INSTRUCTIONS FOR USE

PRALUENT (ALIROCUMAB) 75 MG SOLUTION FOR INJECTION IN A PRE-FILLED PEN

IMPORTANT INFORMATION

  • The device is a single use disposable pen. It contains 75 mg of PRALUENT (alirocumab) in 1 mL.
  • The PRALUENT pen contains medicine prescribed by your doctor.
  • The medicine is injected under your skin and can be given by yourself or someone else (caregiver).
  • This pen can only be used for one single injection, and must be discarded after use.
DoDo not
  • Keep the PRALUENT pen out of the reach of children.
  • Read all of the instructions carefully before using the PRALUENT pen.
  • Follow these instructions every time you use a PRALUENT pen.
  • Store unused pens in the refrigerator at 36°F to 46°F (2°C to 8°C). For detailed storage conditions see separate Patient Medication Information leaflet for PRALUENT.
  • Do not touch the yellow safety cover.
  • Do not use the pen if it has been dropped or damaged.
  • Do not use the pen if the blue cap is missing or not securely attached.
  • Do not re-use a pen.
  • Do not shake the pen.
  • Do not freeze the pen.
  • Do not expose the pen to extreme heat.
  • Do not expose the pen to direct sunlight.

Keep this leaflet. If you have questions, ask your doctor, pharmacist or nurse or call the sanofi-aventis number on the patient leaflet.

The parts of the PRALUENT pen are shown in this picture.

STEP A: GETTING READY FOR AN INJECTION

Before you start you will need:

  • the PRALUENT pen,
  • alcohol wipes,

  • cotton ball or gauze,
  • a puncture-resistant container (see STEP B-8).
  • Look at the label on the pen.

    • Check that you have the correct product and the correct dose.
    • Check the use by date: do not use if this date has passed.

Green button

Body

Window

Yellow safety cover

Needle inside

Blue cap

For single use only

  1. 2.

    Look at the window.

    • Check the liquid is clear, colorless to pale yellow and free from particles - if not, do not use (see picture A).
    • You may see an air bubble. This is normal.
    • Do not use if the window appears solid yellow (see picture B).
    • Do not use this medicine if the solution is discolored or cloudy, or if it contains visi-ble flakes or particles.
  1. 3.

    Let the pen warm up at room temperature for 30 to 40 minutes.

    • This is important for administering the entire dose and helps minimize discomfort.
    • Take PRALUENT out of the refrigerator to warm up before using.
    • Do not heat the pen; let it warm up on its own.
    • Use the pen as soon as possible after it has warmed up.
    • Do not put the pen back in the refrigerator.

30-40

minutes

  1. 4.

    Prepare the injection site.

    • Wash your hands with soap and water and dry with a towel.
    • Clean skin in the injection area with an alcohol wipe.
    • You can inject into your (see below picture):

      • thigh
      • belly (except for the 5 cm/2 inch area around your navel)
      • upper arm
    • You can stand or sit to give yourself an injection.

Important:

  • Change (rotate) your injection site each time you give yourself an injection. If you need to use the same injection area, make sure it is not the same spot on the site you used last time.
  • Do not inject into areas where the skin is injured, tender, hard, red, or hot. Do not in-ject PRALUENT into areas with visible veins, scars or stretch marks

STEP B: HOW TO INJECT

  1. 1.

    After completing all steps in “STEP A: GETTING READY FOR AN INJECTION”, pull off the blue cap

    • Do not pull off the cap until you are ready to inject.
    • Do not put the blue cap back on.
  1. 2. Hold the PRALUENT pen like this.
  2. • Do not touch the yellow safety cover.
  3. • Make sure you can see the window.
  1. 3.

    Press the yellow safety cover on your skin at roughly a 90° angle.

    • Press and firmly hold the pen against your body until the yellow safety cover is no longer visible. The pen will not work if the yellow safety cover is not depressed fully.
    • If needed, pinch the skin to make sure the injection site is firm.
  1. 4.

    Push and immediately release the green button with your thumb.

    • You will hear a click. Your injection has now started.
    • The window will start to turn yellow.
  1. 5.

    Keep holding the pen against your skin after releasing the button

    • The injection may take up to 20 seconds.
  1. 6.

    Check the window has turned yellow, before removing the pen.

    • Do not remove the pen until the entire window has turned yellow.
    • Your injection is complete, when the window has turned completely yellow, you may hear a second click.
    • If the window does not turn completely yellow, call 1-800-265-7927 for help. Do not give yourself a second dose without speaking to your doctor, pharmacist or nurse.
  1. 7.

    Pull pen away from your skin.

    • Do not rub the skin after the injection.
    • If you see any blood, press a cotton ball or gauze on the site until the bleeding stops.
  1. 8.

    Discard pen and cap

    • Do not put the blue cap back on.
    • Throw away the pen in a puncture-resistant container immediately after they have been used
    • Dispose of used container according to your local regulations.
    • Always keep the container out of the reach of children.

PRALUENT (alirocumab) 150 MG SOLUTION FOR INJECTION IN A PRE-FILLED PEN

IMPORTANT INFORMATION

  • The device is a single use disposable pen. It contains 150 mg of PRALUENT (aliro-cumab) in 1 mL.
  • The PRALUENT pen contains medicine prescribed by your doctor.
  • The medicine is injected under your skin and can be given by yourself or someone else (caregiver).
  • This pen can only be used for one single injection, and must be discarded after use.
DoDo not
  • Keep the PRALUENT pen out of the reach of children.
  • Read all of the instructions carefully before using the PRALUENT pen.
  • Follow these instructions every time you use a PRALUENT pen.
  • Store unused pens in the refrigerator at 36°F to 46°F (2°C to 8°C). For detailed storage conditions see separate Patient Medications Information leaflet for PRALUENT.
  • Do not touch the yellow safety cover.
  • Do not use the pen if it has been dropped or damaged.
  • Do not use the pen if the blue cap is missing or not securely attached.
  • Do not re-use a pen.
  • Do not shake the pen.
  • Do not freeze the pen.
  • Do not expose the pen to extreme heat.
  • Do not expose the pen to direct sunlight.

Keep this leaflet. If you have questions, ask your doctor, pharmacist or nurse or call the sanofi-aventis number on the patient leaflet.

The parts of the PRALUENT pen are shown in this picture.

STEP A: GETTING READY FOR AN INJECTION

Before you start you will need:

  • the PRALUENT pen,
  • alcohol wipes,
  • cotton ball or gauze,
  • a puncture-resistant container (see STEP B-8).
  • Look at the label on the pen.

    • Check that you have the correct product and the correct dose.
    • Check the use by date: do not use if this date has passed.

Grey button

Body

Window

Yellow safety cover

Needle inside

Blue cap

For single use only

  1. 2.

    Look at the window.

    • Check the liquid is clear, colorless to pale yellow and free from particles - if not, do not use (see picture A).
    • You may see an air bubble. This is normal.
    • Do not use if the window appears solid yellow (see picture B).
    • Do not use this medicine if the solution is discolored or cloudy, or if it contains visi-ble flakes or particles.
  1. 3.

    Let the pen warm up at room temperature for 30 to 40 minutes.

    • This is important for administering the entire dose and helps minimize discomfort.
    • Take PRALUENT out of the refrigerator to warm up before using.
    • Do not heat the pen, let it warm up on its own.
    • Use the pen as soon as possible after it has warmed up.
    • Do not put the pen back in the refrigerator.

30-40

minutes

  1. 4.

    Prepare the injection site.

    • Wash your hands with soap and water and dry with a towel.
    • Clean skin in the injection area with an alcohol wipe.
    • You can inject into your (see below picture):

      • thigh
      • belly (except for the 5 cm/2 inch area around your navel)
      • upper arm
    • You can stand or sit to give yourself an injection.

Important:

  • Change (rotate) your injection site each time you give yourself an injection. If you need to use the same injection area, make sure it is not the same spot on the site you used last time.
  • Do not inject into areas where the skin is injured, tender, hard, red, or hot. Do not in-ject PRALUENT into areas with visible veins, scars or stretch marks.

STEP B: HOW TO INJECT

  1. 1.

    After completing all steps in “STEP A: GETTING READY FOR AN INJECTION”, pull off the blue cap

    • Do not pull off the cap until you are ready to inject.
    • Do not put the blue cap back on.
  1. 2.

    Hold the PRALUENT pen like this.

    • Do not touch the yellow safety cover.
    • Make sure you can see the window.
  1. 3.

    Press the yellow safety cover on your skin at roughly a 90° angle.

    • Press and firmly hold the pen against your body until the yellow safety cover is no longer visible. The pen will not work if the yellow safety cover is not depressed fully.
    • If needed, pinch the skin to make sure the injection site is firm.
  1. 4.

    Push and immediately release the grey button with your thumb.

    • You will hear a click. Your injection has now started.
    • The window will start to turn yellow.
  1. 5.

    Keep holding the pen against your skin after releasing the button

    • The injection may take up to 20 seconds.
  1. 6.

    Check the window has turned yellow, before removing the pen.

    • Do not remove the pen until the entire window has turned yellow.
    • Your injection is complete, when the window has turned completely yellow, you may hear a second click.
    • If the window does not turn completely yellow, call 1-800-265-7927 for help. Do not give yourself a second dose without speaking to your doctor, pharmacist or nurse.
  1. 7.

    Pull pen away from your skin.

    • Do not rub the skin after the injection.
    • If you see any blood, press a cotton ball or gauze on the site until the bleeding stops.
  1. 8.

    Discard pen and cap

    • Do not put the blue cap back on.
    • Throw away the pen in a puncture-resistant container immediately after they have been used
    • Dispose of used container according to your local regulations.
    • Always keep the container out of the reach of children.

PRALUENT (alirocumab) 75 MG SOLUTION FOR INJECTION IN A PRE-FILLED SYRINGE

IMPORTANT INFORMATION

  • The device is a single use pre-filled syringe. It contains 75 mg of PRALUENT (aliro-cumab) in 1 mL.
  • The PRALUENT syringe contains medicine prescribed by your doctor.
  • The medicine is injected under your skin and can be given by yourself or someone else (caregiver).
  • This syringe can only be used for one single injection, and must be discarded after use.
DoDo not
  • Keep the PRALUENT syringe out of the reach of children.
  • Read all of the instructions carefully before using the PRALUENT syringe.
  • Follow these instructions every time you use a PRALUENT syringe.
  • Store unused syringes in the refrigerator at 36°F to 46°F (2°C to 8°C). For detailed storage conditions see separate Patient Medications Information leaflet for PRALUENT.
  • Do not touch the needle.
  • Do not use the syringe if it has been dropped or damaged.
  • Do not use the syringe if the gray needle cap is missing or not securely attached.
  • Do not re-use a syringe.
  • Do not shake the syringe.
  • Do not freeze the syringe.
  • Do not expose the syringe to extreme heat.
  • Do not expose the syringe to direct sun-light.

Keep this leaflet. If you have questions, ask your doctor, pharmacist or nurse or call the sanofi-aventis number on the patient leaflet.

The parts of the PRALUENT syringe are shown in this picture.

STEP A: GETTING READY FOR AN INJECTION

Before you start you will need:

  • the PRALUENT syringe,
  • alcohol wipes,
  • cotton ball or gauze,
  • a puncture-resistant container (see STEP B-6).
  • Before you start.

    • Take the syringe out of the packaging by holding the syringe body.
  1. 2.

    Look at the label on the syringe.

    • Check that you have the correct product and the correct dose (green plunger for 75 mg/ml). Check the use by date - do not use if this date has passed.
    • Check the liquid is clear, colorless to pale yellow and free from particles - if not, do not use.
    • Check that the syringe is not open or damaged.
  2. 3.

    Let the syringe warm up at room temperature for 30 to 40 minutes.

    • This is important for administering the entire dose and helps minimize discomfort.
    • Take PRALUENT out of the refrigerator to warm up before using.
    • Do not heat the syringe, let it warm up on its own.
    • Use the syringe as soon as possible after it has warmed up.
    • Do not put the syringe back in the refrigerator.
  3. 4.

    Prepare the injection site.

    • Wash your hands with soap and water and dry with a towel.
    • Clean skin in the injection area with an alcohol wipe.
    • You can inject into your (see below picture):

      • thigh
      • belly (except for the 5 cm/2 inch area around your navel)
      • upper arm
    • You can stand or sit to give yourself an injection.

Important:

  • Change (rotate) your injection site each time you give yourself an injection. If you need to use the same injection area, make sure it is not the same spot on the site you used last time.
  • Do not inject into areas where the skin is injured, tender, hard, red, or hot. Do not in-ject PRALUENT into areas with visible veins, scars or stretch marks.

STEP B: HOW TO INJECT

  1. 1.

    After completing all steps in “STEP A: GETTING READY FOR AN INJECTION”, pull off the needle cap.

    • Do not pull off the cap until you are ready to inject.
    • Hold the syringe in the middle of the syringe body with the needle pointing away from you.
    • Keep your hand away from the plunger.
    • Do not get rid of any air bubbles in the syringe before the injection.
    • Do not put the grey cap back on.
  1. 2.

    If needed pinch the skin.

    • Use your thumb and first finger to pinch a fold of skin at the injection site.
    • Hold the skin like this for the whole injection.
  1. 3.

    Insert the needle into the fold of skin with a quick dart-like motion.

    • Use a 90º angle if you can pinch 5 cm/2 inches of skin.
    • Use a 45° angle if you can only pinch 2 cm/1 inch of skin.
  1. 4.

    Push the plunger down.

    • Inject all of the solution by slowly and steadily pushing down the plunger.
  1. 5.

    Before you remove the needle check the syringe is empty.

    • Do not remove the syringe until it is completely empty.
    • Pull the needle out of the skin at the same angle as it was inserted.
    • Do not rub the skin after the injection.
    • If you see any blood, press a cotton ball or gauze on the site until the bleeding stops.
  1. 6.

    Discard syringe and cap

    • Do not put the grey needle cap back on.
    • Do not re-use the syringe.
    • Throw away the syringe and the cap in a puncture-resistant container immediately af-ter they have been used
    • Dispose of used container according to your local regulations.
    • Always keep the container out of the reach of children

PRALUENT (alirocumab) 150 MG SOLUTION FOR INJECTION IN A PRE-FILLED SYRINGE

IMPORTANT INFORMATION

  • The device is a single use pre-filled syringe. It contains 150 mg of PRALUENT (aliro-cumab) in 1 mL.
  • The PRALUENT syringe contains medicine prescribed by your doctor.
  • The medicine is injected under your skin and can be given by yourself or someone else (caregiver).
  • This syringe can only be used for one single injection, and must be discarded after use.
DoDo not
  • Keep the PRALUENT syringe out of the reach of children.
  • Read all of the instructions carefully before using the PRALUENT syringe.
  • Follow these instructions every time you use a PRALUENT syringe.
  • Store unused syringes in the refrigerator at 36°F to 46°F (2°C to 8°C). For detailed storage conditions see separate Patient Medications Information leaflet for PRALUENT.
  • Do not touch the needle.
  • Do not use the syringe if it has been dropped or damaged.
  • Do not use the syringe if the gray needle cap is missing or not securely attached.
  • Do not re-use a syringe.
  • Do not shake the syringe.
  • Do not freeze the syringe.
  • Do not expose the syringe to extreme heat.
  • Do not expose the syringe to direct sun-light.

Keep this leaflet. If you have questions, ask your doctor, pharmacist or nurse or call the sanofi-aventis number on the patient leaflet.

The parts of the PRALUENT syringe are shown in this picture.

STEP A: GETTING READY FOR AN INJECTION

Before you start you will need:

  • the PRALUENT syringe,
  • alcohol wipes,
  • cotton ball or gauze,
  • a puncture-resistant container (see STEP B-6).
  • Before you start.

    • Take the syringe out of the packaging by holding the syringe body.
  1. 2.

    Look at the label on the syringe.

    • Check that you have the correct product and the correct dose (gray plunger for 150 mg/ml). Check the use by date - do not use if this date has passed.
    • Check the liquid is clear, colorless to pale yellow and free from particles - if not, do not use.
    • Check that the syringe is not open or damaged.
  2. 3.

    Let the syringe warm up at room temperature for 30 to 40 minutes.

    • This is important for administering the entire dose and helps minimize discomfort.
    • Take PRALUENT out of the refrigerator to warm up before using.
    • Do not heat the syringe, let it warm up on its own.
    • Use the syringe as soon as possible after it has warmed up.
    • Do not put the syringe back in the refrigerator.
  3. 4.

    Prepare the injection site.

    • Wash your hands with soap and water and dry with a towel.
    • Clean skin in the injection area with an alcohol wipe.
    • You can inject into your (see below picture):

      • thigh
      • belly (except for the 5 cm/2 inch area around your navel)
      • upper arm
    • You can stand or sit to give yourself an injection.

Important:

  • Change (rotate) your injection site each time you give yourself an injection. If you need to use the same injection area, make sure it is not the same spot on the site you used last time.
  • Do not inject into areas where the skin is injured, tender, hard, red, or hot. Do not in-ject PRALUENT into areas with visible veins, scars or stretch marks

30-40

minutes

STEP B: HOW TO INJECT

  1. 1.

    After completing all steps in “STEP A: GETTING READY FOR AN INJECTION”, pull off the needle cap.

    • Do not pull off the cap until you are ready to inject.
    • Hold the syringe in the middle of the syringe body with the needle pointing away from you.
    • Keep your hand away from the plunger.
    • Do not get rid of any air bubbles in the syringe before the injection.
    • Do not put the gray cap back on.
  1. 2.

    If needed pinch the skin.

    • Use your thumb and first finger to pinch a fold of skin at the injection site.
    • Hold the skin like this for the whole injection.
  1. 3.

    Insert the needle into the fold of skin with a quick dart-like motion.

    • Use a 90º angle if you can pinch 5 cm/2 inches of skin.
    • Use a 45° angle if you can only pinch 2 cm/1 inch of skin.
  1. 4.

    Push the plunger down.

    • Inject all of the solution by slowly and steadily pushing down the plunger.
  1. 5.

    Before you remove the needle check the syringe is empty.

    • Do not remove the syringe until it is completely empty.
    • Pull the needle out of the skin at the same angle as it was inserted.
    • Do not rub the skin after the injection.
    • If you see any blood, press a cotton ball or gauze on the site until the bleeding stops.
  1. 6.

    Discard syringe and cap

    • Do not put the grey needle cap back on.
    • Do not re-use the syringe.
    • Throw away the syringe and cap in a puncture-resistant container immediately after they have been used.
    • Dispose of used containers according to your local guidelines.
    • Always keep the container out of the reach of children.

About this document

Source: Health Canada – Drug Product Database (DPD) and product monographs · DIN (Drug Identification Number): 02453754

Revision date stated in the text: December 6, 2019

Found a mistake? Write to us via the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Drug information for Praluent (Sanofi-Aventis Canada, 75 mg, 150 mg)

Rx or OTC
Prescription (Rx)?
DIN 02453754, 02453762
Schedule(s) PRESCRIPTION; SCHEDULE D
Active ingredient(s) Alirocumab
Dosage form(s) Solution
Route(s) of administration Subcutaneous
Drug class (WHO ATC)
  1. C Cardiovascular system drugs
    1. C10 Lipid modifying agents
      1. C10A Lipid modifying agents, plain
        1. C10AX Other lipid modifying agents
          1. C10AX14 Alirocumab
Company SANOFI-AVENTIS CANADA INC
Current status Cancelled Post Market
Current status date March 4, 2021
Strengths and forms
DIN Strength Dosage form(s) Current status
02453754 75 MG Solution Cancelled Post Market March 4, 2021
02453762 150 MG Solution Cancelled Post Market March 4, 2021

Source: Health Canada – Drug Product Database (DPD) and product monographs, data as of November 1, 2026. Data from the Health Canada Drug Product Database, as published there. Not a substitute for the advice of a doctor or pharmacist.